3D Printed Organs: Bioprinting Livers for Transplant Patients

Medical technology is moving at a staggering pace. The ability to create perfectly viable human tissue in laboratories is no longer science fiction. Today, bioengineers are actively 3D printing liver tissue, offering a massive leap forward for medical research and bringing us closer to solving the global organ shortage for transplant patients.

The Global Organ Shortage Crisis

The demand for healthy organs far exceeds the available supply. In the United States alone, over 100,000 people are currently on the national transplant waiting list. The liver is the second most needed organ, right behind the kidney. Patients with end-stage liver disease often wait years for a donor match, and tragically, thousands pass away before receiving one.

Because the liver is the primary filtration system for the human body, mechanical alternatives like dialysis are incredibly difficult to replicate effectively over long periods. This urgent need has pushed scientists to look beyond human donors and explore manufacturing human tissue from scratch.

How 3D Bioprinting Actually Works

Standard 3D printers use plastics or metals to build objects layer by layer. Bioprinters use the exact same mechanical concept but swap out the plastic for something called bioink.

Bioink is a mixture of living human cells and a supportive hydrogel. The hydrogel acts as a temporary scaffold. It is typically made from natural materials like alginate, gelatin, or collagen. This gel protects the fragile cells during the printing process and gives them a structure to cling to while they multiply and form solid tissue.

For bioprinting a liver, scientists need to load the bioink with very specific cellular building blocks. The primary cells used are hepatocytes. These are the workhorse cells of the liver responsible for filtering toxins and producing bile. Researchers also mix in endothelial cells to help form blood vessels and stellate cells to support the overall liver structure.

Major companies provide the hardware and materials to make this happen. BICO (formerly known as CELLINK) is a leading provider of these specialized bioprinters and bioinks, selling machines to research universities and pharmaceutical companies worldwide.

The Pioneers of Bioprinted Liver Tissue

Several biotechnology companies are racing to perfect 3D printed liver tissues. A standout in this field is Organovo. Based in California, Organovo developed a product called ExVive3D Human Liver Tissue.

Right now, ExVive3D is primarily used by major pharmaceutical companies for toxicology testing. Before a new drug can be tested on humans, drug makers need to know if it will damage the liver. Historically, this testing was done on animals or flat layers of cells in a petri dish. Neither method accurately mimics a complex, three-dimensional human liver.

Organovo’s 3D printed liver tissue survives for weeks in a laboratory setting. It reacts to toxins exactly like a native human liver. This allows drug companies to spot dangerous side effects early, saving billions of dollars and preventing harmful drugs from entering human clinical trials.

Another major player is United Therapeutics. They recently partnered with the printing giant 3D Systems to create incredibly complex organ scaffolds. While much of their highly publicized recent work has focused on 3D printed lungs, the underlying technology of printing ultra-high-resolution scaffolds (down to the micron level) is directly applicable to printing human livers.

The Path to Human Transplants

While printing a fully functional, full-sized liver for transplant is the ultimate goal, it will not happen overnight. The medical community expects progress to happen in distinct phases.

The first phase is already here with laboratory drug testing. The second phase involves bioprinting “liver patches.” These are small, functional pieces of liver tissue. Instead of replacing a failing liver entirely, surgeons could graft a 3D printed patch directly onto a patient’s diseased liver. Because the liver has a unique natural ability to regenerate, a functional patch could boost the organ’s performance enough to keep a patient alive while they wait for a full transplant. Organovo has already been working toward FDA clearance for exactly this type of therapeutic liver tissue.

The final phase is the transplantation of a complete, bioprinted solid organ. Industry experts suggest this milestone is still 10 to 15 years away due to several massive biological engineering hurdles.

The Vascularization Challenge

The single biggest roadblock to printing a full liver is vascularization. A liver is a dense, highly vascular organ. It requires a massive amount of blood flow to bring in oxygen and sweep away toxins.

If you print a thick block of liver tissue, the cells in the very center will quickly suffocate and die without a dedicated blood supply. You cannot just print the cells. You must also print an intricate, microscopic network of veins, arteries, and capillaries.

Researchers at institutions like Harvard University and Rice University are tackling this by using sacrificial inks. They print a complex web of bioink made from sugar or gelatin inside the tissue. Once the tissue sets, they flush the structure with warm water. The sacrificial ink melts away, leaving hollow tubes behind. Endothelial cells are then pumped into these hollow channels, where they attach to the walls and grow into actual human blood vessels.

Solving the Rejection Problem

One of the most exciting aspects of 3D printed organs is the potential to eliminate organ rejection. When a patient receives a traditional donor liver, their immune system recognizes the new organ as a foreign invader. The patient must take heavy immunosuppressant drugs for the rest of their life to prevent their body from attacking the new liver.

With bioprinting, scientists can take a simple skin or fat biopsy from the transplant patient. They can genetically reprogram those cells back into a stem cell state (known as induced pluripotent stem cells). These stem cells are then coaxed into becoming liver cells and used to create the bioink. Because the resulting 3D printed liver is made from the patient’s exact DNA, the immune system will accept it as its own tissue.

Lowering the Cost of Innovation

The speed of this research is accelerating rapidly due to falling hardware costs. Just a decade ago, a bioprinter cost hundreds of thousands of dollars, limiting access to a few elite laboratories. Today, companies like Allevi (a subsidiary of 3D Systems) sell entry-level, highly capable desktop bioprinters for around $10,000. This price drop allows smaller universities and independent biotech startups to join the race, bringing us closer to viable human transplants every single day.

Frequently Asked Questions

How long until 3D printed livers are available for full transplant?

Experts estimate that printing a full, solid liver for human transplantation is still 10 to 15 years away. However, smaller bioprinted liver patches meant to assist a failing liver could enter clinical trials much sooner.

What is bioink made of?

Bioink is a combination of living human cells and a thick hydrogel base. For liver printing, the cells are usually hepatocytes and endothelial cells. The hydrogel is often made from natural materials like gelatin, collagen, or alginate to provide structural support while the cells bond together.

Will a patient’s body reject a 3D printed liver?

If the 3D printed liver is created using the patient’s own cellular material, the risk of rejection drops to nearly zero. Scientists can harvest a patient’s cells, convert them into stem cells, grow them into liver cells, and use them in the bioprinting process. This eliminates the need for lifelong anti-rejection medications.